Abbott supported its CE mark approval with data from its FOCALFLEX CE mark study. The global clinical trial, conducted across ...
Interruption or Discontinuation After One Month Following Implant Procedure Posed ‘Low and No Increased Risk’ of Stent Thrombosis at One Year in Clinical Studies MINNEAPOLIS –– Of relevance to the ...
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on addressing degenerative diseases, announced today the submission of a design ...
ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results